APC and colorectal carcinoma: Recently, TNKS inhibitors such as XAV939, IWR-1, G007-LK, and NVP-TNKS656 have been reported to show inhibition of cell proliferation in β-catenin-dependent CRC cells with APC mutations [7,18,19,20,21].